PerZeption Receives NEI SBIR Grant for AMD Photostress Recovery Test
PerZeption receives NEI SBIR grant to develop a photostress recovery test for AMD on tablet hardware, aiming to detect...
Lyell completes LYL273 manufacturing transfer, delays Phase 1/2 timeline
Lyell completes LYL273 manufacturing transfer to its Bothell facility, though the Phase 1/2 colorectal cancer trial now faces enrollment...
China Accepts NCX 470 NDA for Review in Glaucoma Treatment
China's drug regulator accepts NCX 470 NDA for review, advancing Nicox's nitric oxide-donating glaucoma drop toward potential approval in...
What the FDA’s New Psychedelic Framework Actually Means for the Clinic
FDA's September 2026 NEJM framework for psychedelic drugs reshapes trial design, REMS requirements, and patient access for psilocybin and...
Headlands Research Opens Grand Rapids Site Led by Rheumatology Investigator
Headlands Research opens Grand Rapids site led by rheumatology investigator Eric Slavin, expanding clinical trial capacity in the Midwest.
Velocity Clinical, Stitch expand partnership across 70+ sites to boost screening attendance
Velocity Clinical and Stitch expand partnership across 70+ sites, achieving a 9-point reduction in no-show rates and boosting screening...
Phase 3 study shows aQIVc superior to comparators in older adults
Phase 3 study shows aQIVc demonstrated superior immunogenicity against influenza strains in adults 50 and older, with responses sustained...
FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer
FDA clears Prelude's PRT13722 Phase 1 trial in HR-positive breast cancer, advancing the oral KAT6A degrader toward patient enrollment.
Women’s Hearts, Underserved by Design: Anteris Technologies President David St. Denis on Closing Structural Heart’s Most Overlooked Gap
The problem isn't that fewer women get aortic stenosis. It's that the entire pipeline, from diagnosis to device, was...
When the ER Is Not an Option: Milestone’s CMO on Bringing AFib Rate Control Home
The FDA approval of etripamil for PSVT occurred in December, 2025. Investigation about a potential role of etripamil in...